These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


943 related items for PubMed ID: 11085539

  • 1. Activation of hepatocyte growth factor/scatter factor in colorectal carcinoma.
    Kataoka H, Hamasuna R, Itoh H, Kitamura N, Koono M.
    Cancer Res; 2000 Nov 01; 60(21):6148-59. PubMed ID: 11085539
    [Abstract] [Full Text] [Related]

  • 2. Pericellular activation of hepatocyte growth factor/scatter factor (HGF/SF) in colorectal carcinomas: roles of HGF activator (HGFA) and HGFA inhibitor type 1 (HAI-1).
    Kataoka H, Itoh H, Hamasuna R, Meng JY, Koono M.
    Hum Cell; 2001 Mar 01; 14(1):83-93. PubMed ID: 11436357
    [Abstract] [Full Text] [Related]

  • 3. Expression of hepatocyte growth factor/scatter factor, its activator, inhibitors and the c-Met receptor in human cancer cells.
    Parr C, Jiang WG.
    Int J Oncol; 2001 Oct 01; 19(4):857-63. PubMed ID: 11562767
    [Abstract] [Full Text] [Related]

  • 4. The scatter factor/hepatocyte growth factor: c-met pathway in human embryonal central nervous system tumor malignancy.
    Li Y, Lal B, Kwon S, Fan X, Saldanha U, Reznik TE, Kuchner EB, Eberhart C, Laterra J, Abounader R.
    Cancer Res; 2005 Oct 15; 65(20):9355-62. PubMed ID: 16230398
    [Abstract] [Full Text] [Related]

  • 5. Hepatocyte growth factor (HGF), HGF activator, and c-Met in synovial tissues in rheumatoid arthritis and osteoarthritis.
    Nagashima M, Hasegawa J, Kato K, Yamazaki J, Nishigai K, Ishiwata T, Asano G, Yoshino S.
    J Rheumatol; 2001 Aug 15; 28(8):1772-8. PubMed ID: 11508578
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Activation of hepatocyte growth factor activator zymogen (pro-HGFA) by human kallikrein 1-related peptidases.
    Mukai S, Fukushima T, Naka D, Tanaka H, Osada Y, Kataoka H.
    FEBS J; 2008 Mar 15; 275(5):1003-17. PubMed ID: 18221492
    [Abstract] [Full Text] [Related]

  • 8. Hepatocyte growth factor/scatter factor (HGF/SF) is produced by human bone marrow stromal cells and promotes proliferation, adhesion and survival of human hematopoietic progenitor cells (CD34+).
    Weimar IS, Miranda N, Muller EJ, Hekman A, Kerst JM, de Gast GC, Gerritsen WR.
    Exp Hematol; 1998 Aug 15; 26(9):885-94. PubMed ID: 9694510
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Hepatocyte growth factor/scatter factor-induced activation of MEK and PI3K signal pathways contributes to expression of proangiogenic cytokines interleukin-8 and vascular endothelial growth factor in head and neck squamous cell carcinoma.
    Dong G, Chen Z, Li ZY, Yeh NT, Bancroft CC, Van Waes C.
    Cancer Res; 2001 Aug 01; 61(15):5911-8. PubMed ID: 11479233
    [Abstract] [Full Text] [Related]

  • 11. Defect of pro-hepatocyte growth factor activation by fibroblasts in idiopathic pulmonary fibrosis.
    Marchand-Adam S, Fabre A, Mailleux AA, Marchal J, Quesnel C, Kataoka H, Aubier M, Dehoux M, Soler P, Crestani B.
    Am J Respir Crit Care Med; 2006 Jul 01; 174(1):58-66. PubMed ID: 16574935
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Hepatocyte growth factor/scatter factor induces feedback up-regulation of CD44v6 in melanoma cells through Egr-1.
    Recio JA, Merlino G.
    Cancer Res; 2003 Apr 01; 63(7):1576-82. PubMed ID: 12670907
    [Abstract] [Full Text] [Related]

  • 15. HGF/SF and its receptor c-MET play a minor role in the dissemination of human B-lymphoma cells in SCID mice.
    Weimar IS, Weijer K, van den Berk PC, Muller EJ, Miranda N, Bakker AQ, Heemskerk MH, Hekman A, de Gast GC, Gerritsen WR.
    Br J Cancer; 1999 Sep 01; 81(1):43-53. PubMed ID: 10487611
    [Abstract] [Full Text] [Related]

  • 16. Expression of hepatocyte growth factor activator and hepatocyte growth factor activator inhibitor type 1 in human hepatocellular carcinoma.
    Nagata K, Hirono S, Ido A, Kataoka H, Moriuchi A, Shimomura T, Hori T, Hayashi K, Koono M, Kitamura N, Tsubouchi H.
    Biochem Biophys Res Commun; 2001 Nov 23; 289(1):205-11. PubMed ID: 11708800
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Imbalance in the pro-hepatocyte growth factor activation system in bleomycin-induced lung fibrosis in mice.
    Phin S, Marchand-Adam S, Fabre A, Marchal-Somme J, Bantsimba-Malanda C, Kataoka H, Soler P, Crestani B.
    Am J Respir Cell Mol Biol; 2010 Mar 23; 42(3):286-93. PubMed ID: 19448157
    [Abstract] [Full Text] [Related]

  • 19. Conformational lability in serine protease active sites: structures of hepatocyte growth factor activator (HGFA) alone and with the inhibitory domain from HGFA inhibitor-1B.
    Shia S, Stamos J, Kirchhofer D, Fan B, Wu J, Corpuz RT, Santell L, Lazarus RA, Eigenbrot C.
    J Mol Biol; 2005 Mar 11; 346(5):1335-49. PubMed ID: 15713485
    [Abstract] [Full Text] [Related]

  • 20. Immunohistochemical expression of HGF, c-MET and transcription factor STAT3 in colorectal tumors.
    Trovato M, Vitarelli E, Grosso M, Alesci S, Benvenga S, Trimarchi F, Barresi G.
    Eur J Histochem; 2004 Mar 11; 48(3):291-7. PubMed ID: 15590419
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 48.